On March 21, 2024, Amniotics AB (publ) (the "Company") disclosed a press
release with information on the Company's financial situation.
On March 22, 2024, Magle Chemoswed Holding AB ("Magle Chemoswed") disclosed a
public takeover offer to the shareholders in the Company.
On May 20, 2024, Magle Chemoswed disclosed a press release with information
that the offer would not be completed and that shareholders in the Company who
had accepted the offer would be released from their obligations under the
offer.
With reference to the above, Nasdaq Stockholm AB decides that the observation
status of the shares in Amniotics AB (publ) (AMNI, ISIN code SE0015961016,
order book ID 228566) shall be updated.
For further information about this exchange notice please contact Enforcement &
Investigations, telephone +46 8 405 70 50.
Nasdaq Stockholm AB© 2024 GlobeNewswire
